Guess Who Picked Concert Pharmaceuticals Inc. (NYSE:CNCE) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Concert Pharmaceuticals Inc. (NYSE:CNCE) reported that Great Point Partners has picked up 2,101,301 of common stock as of 2017-03-16.
The acquisition brings the aggregate amount owned by Great Point Partners to a total of 2,101,301 representing a 9.41% stake in the company.
For those not familiar with the company, Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through the development of pharmaceutical products on its own behalf or in collaboration with others segment. It has clinical candidates under development, including AVP-786, CTP-656, CTP-730 and JZP-386. The Company’s deuterated chemical entity platform (DCE Platform) enables it to identify compounds for deuteration and to design, evaluate, develop and manufacture deuterated compounds. The Company is utilizing its DCE Platform to discover and develop product candidates for a range of indications. The Company’s product candidate, CTP-656, is a next generation potentiator that the Company is initially developing for the treatment of cystic fibrosis in patients having gating mutations, including the G551D mutation. AVP-786 is a combination of a deuterated dextromethorphan analog and a low dose of quinidine.
A glance at Concert Pharmaceuticals Inc. (NYSE:CNCE)’s key stats reveals a current market capitalization of 357.71 Million based on 22.33 Million shares outstanding and a price at last close of $16.19 share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-05-10, Tung picked up 19,610 at a purchase price of $10.55. This brings their total holding to 538,965 as of the date of the filing.
On the sell side, the most recent transaction saw Hutt unload 22,123 shares at a sale price of $9.81. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Concert Pharmaceuticals Inc. (NYSE:CNCE) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Comstock Resources Inc. (NYSE:CRK) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Comstock Resources Inc. (NYSE:CRK) reported that Westcott Carl H has picked up 1,135,602 of common stock as of 2017-03-16.
The acquisition brings the aggregate amount owned by Westcott Carl H to a total of 1,135,602 representing a 7.47% stake in the company.
For those not familiar with the company, Comstock Resources, Inc. is an energy company engaged in the acquisition, exploration, development and production of oil and natural gas in the United States. The Company operates in the segment of exploration and production of oil and natural gas. The Company’s oil and gas operations are concentrated in Texas and Louisiana. Its operations are focused in two operating areas: East Texas/North Louisiana and South Texas. The Company’s properties in the East Texas/North Louisiana region include approximately 80,660 acres in the Haynesville or Bossier shale formations. The Company’s Eagleville field includes approximately 30,220 acres located in the oil window of the Eagle Ford shale in South Texas. The Company owns interests in over 1,575 producing oil and natural gas wells, and operates over 950 of these wells. The Company owns interests in over 20 wells in the Rosita field, located in Duval County, Texas.
A glance at Comstock Resources Inc. (NYSE:CRK)’s key stats reveals a current market capitalization of 138.97 Million based on 15.20 Million shares outstanding and a price at last close of $8.90 share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-11-15, Martin picked up 5,500 at a purchase price of $8.95. This brings their total holding to 34,524 as of the date of the filing.
On the sell side, the most recent transaction saw Allison unload 8,000 shares at a sale price of $10.12. This brings their total holding to 393,919.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Comstock Resources Inc. (NYSE:CRK) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Fir Tree is Buying Eco-Stim Energy Solutions Inc. (NASDAQ:ESES) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Eco-Stim Energy Solutions Inc. (NASDAQ:ESES) reported that Fir Tree has picked up 2,030,436 of common stock as of 2017-03-16.
The acquisition brings the aggregate amount owned by Fir Tree to a total of 2,030,436 representing a 13.5% stake in the company.
For those not familiar with the company, Eco-Stim Energy Solutions, Inc. is an oilfield services company. The Company provides well stimulation, coiled tubing and field management services to the upstream oil and gas industry. The Company focuses on the active shale and unconventional oil and natural gas basins outside the United States and it has commenced operations in Argentina. The Company operates well stimulation fleets, coiled tubing units and other downhole completion equipment, as well as provides sweet spot analysis in shale resource basins using geophysical predictive modeling combined with real-time feedback from down-hole diagnostic tools. The Company offers a pumping fleet, including well-stimulation pumps, nitrogen pumping units and cranes, in both trailer-mounted and skid-mounted configurations. It provides a range of pressure-pumping services, including work-over pumping, well injection and wireline pump downs.
A glance at Eco-Stim Energy Solutions Inc. (NASDAQ:ESES)’s key stats reveals a current market capitalization of 16.58 Million based on 14.42 Million shares outstanding and a price at last close of $1.16 share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-09-22, Bienville picked up 50,874 at a purchase price of $2.28. This brings their total holding to 2,979,534 as of the date of the filing.
On the sell side, the most recent transaction saw Bass unload 1,530,678 shares at a sale price of $1.21. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Eco-Stim Energy Solutions Inc. (NASDAQ:ESES) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Celgene Corp /de/ Picked Up Alliqua Biomedical Inc. (NASDAQ:ALQA) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Alliqua Biomedical Inc. (NASDAQ:ALQA) reported that Celgene Corp /de/ has picked up 8,025,194 of common stock as of 2017-03-16.
The acquisition brings the aggregate amount owned by Celgene Corp /de/ to a total of 8,025,194 representing a 19.9% stake in the company.
For those not familiar with the company, Alliqua BioMedical, Inc. is a provider of advanced wound care solutions. The Company’s businesses include advanced wound care and contract manufacturing. The Company operates through its subsidiaries, such as AquaMed Technologies, Inc. and Choice Therapeutics, Inc. The Company is engaged in developing a suite of advanced wound care solutions that will enable surgeons, clinicians and wound care practitioners to address the challenges in chronic and acute wounds. The Company utilizes hydrogel technology through which hydrogels are manufactured by introducing a hydrophilic polymer into water to create a feed mix. The Company’s commercial wound care portfolio consists of over four product categories, such as Human Biologics; Antimicrobial Protection; Exudate Management and Contract Manufacturing. Human Biologics include BIOVANCE and Extracellular Matrix (ECM). Under Antimicrobial Protection, the Company offers TheraBond 3D Antimicrobial Barrier Systems and SilverSeal.
A glance at Alliqua Biomedical Inc. (NASDAQ:ALQA)’s key stats reveals a current market capitalization of 17.77 Million based on 35.11 Million shares outstanding and a price at last close of $0.599 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-02-27, Celgene picked up 4,000,000 at a purchase price of $0.50. This brings their total holding to 7,046,100 as of the date of the filing.
On the sell side, the most recent transaction saw Kalen unload 24,057,980 shares at a sale price of $0.04. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Alliqua Biomedical Inc. (NASDAQ:ALQA) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Valeant Pharmaceuticals International Inc. (NYSE:VRX) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Valeant Pharmaceuticals International Inc. (NYSE:VRX) reported that Va Partners I, Llc. has picked up 16,937,431 of common stock as of 2017-03-16.
The acquisition brings the aggregate amount owned by Va Partners I, Llc. to a total of 16,937,431 representing a 4.9% stake in the company.
For those not familiar with the company, Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices). It operates through two segments: Developed markets and Emerging markets. In the Developed Markets segment, it focuses on the areas of dermatology, neurology, gastrointestinal disorders, and eye health therapeutic classes. In the Emerging Markets segment, it focuses on primarily on branded generics, OTC products and medical devices. Its pharmaceutical products include Xifaxan, Solodyn and Glumetza. Its OTC products include PreserVision, Biotrue and Boston. Its other generic products include Latanoprost and Metronidazole. Its ophthalmic surgical products include intraocular lenses, such as Akreos, enVista, Crystalens and Trulign.
A glance at Valeant Pharmaceuticals International Inc. (NYSE:VRX)’s key stats reveals a current market capitalization of 3.87 Billion based on 341.19 Million shares outstanding and a price at last close of $11.20 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-15, De picked up 10,000 at a purchase price of $10.80. This brings their total holding to 25,190 as of the date of the filing.
On the sell side, the most recent transaction saw Pershing unload 18,114,432 shares at a sale price of $11.00. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Valeant Pharmaceuticals International Inc. (NYSE:VRX) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Rti Surgical Inc. (NASDAQ:RTIX) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Rti Surgical Inc. (NASDAQ:RTIX) reported that Krensavage Asset Management, Llc. has picked up 3,561,351 of common stock as of 2017-03-16.
The acquisition brings the aggregate amount owned by Krensavage Asset Management, Llc. to a total of 3,561,351 representing a 6.1% stake in the company.
For those not familiar with the company, RTI Surgical, Inc. is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties. It processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes, and manufactures metal and synthetic implants for distribution to hospitals and surgeons. The Company distributes its implants and services in approximately 50 states and in over 45 countries across the world.
A glance at Rti Surgical Inc. (NASDAQ:RTIX)’s key stats reveals a current market capitalization of 219.23 Million based on 58.46 Million shares outstanding and a price at last close of $3.75 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-02, Singer picked up 10,000 at a purchase price of $3.79. This brings their total holding to 30,270 as of the date of the filing.
On the sell side, the most recent transaction saw Smith unload 15,000 shares at a sale price of $4.31. This brings their total holding to 18,225.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Rti Surgical Inc. (NASDAQ:RTIX) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Hongkong Meisheng Culture Picked Jakks Pacific Inc. (NASDAQ:JAKK) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Jakks Pacific Inc. (NASDAQ:JAKK) reported that Hongkong Meisheng Culture Co Ltd. has picked up 1,578,647 of common stock as of 2017-03-16.
The acquisition brings the aggregate amount owned by Hongkong Meisheng Culture Co Ltd. to a total of 1,578,647 representing a 6.8% stake in the company.
For those not familiar with the company, JAKKS Pacific, Inc. is a multi-line, multi-brand toy company. The Company designs, produces, markets and distributes toys and related products, pet toys, consumables and related products, electronics and related products, kids indoor and outdoor furniture, and other consumer products. The Company operates through two business segments: traditional toys and electronics, and role play, novelty and seasonal toys. The traditional toys and electronics segment includes action figures, vehicles, playsets, plush products, dolls, accessories, electronic products, construction toys, infant and pre-school toys, foot to floor ride-on vehicles, wagons and pet products and related products. The role play, novelty and seasonal segment includes role play and dress-up products, novelty toys, seasonal and outdoor products, indoor and outdoor kids’ furniture and Halloween and everyday costume play.
A glance at Jakks Pacific Inc. (NASDAQ:JAKK)’s key stats reveals a current market capitalization of 121.89 Million based on 20.00 Million shares outstanding and a price at last close of $5.55 share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-01-25, Oasis picked up 43,143 at a purchase price of $5.27. This brings their total holding to 1,438,977 as of the date of the filing.
On the sell side, the most recent transaction saw Pine unload 330,200 shares at a sale price of $7.95. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Jakks Pacific Inc. (NASDAQ:JAKK) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Central European Media Enterprises Ltd. (NASDAQ:CETV) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Central European Media Enterprises Ltd. (NASDAQ:CETV) reported that Time Warner Inc. has picked up 268,192,241 of common stock as of 2017-03-16.
The acquisition brings the aggregate amount owned by Time Warner Inc. to a total of 268,192,241 representing a 76.6% stake in the company.
For those not familiar with the company, Central European Media Enterprises Ltd. (CME Ltd.) is a media and entertainment company operating in Central and Eastern Europe. The Company’s assets are held through a series of Dutch and Curacao holding companies. The Company manages its business on a geographical basis, with six segments: Bulgaria, Croatia, the Czech Republic, Romania, the Slovak Republic and Slovenia. The Bulgaria segment operated one general entertainment channel, BTV, and five other channels, including BTV CINEMA, BTV COMEDY, RING.BG, BTV ACTION and BTV LADY, as of December 31, 2016. The Croatia segment operated one general entertainment channel, NOVA TV (Croatia), as of December 31, 2016. The Czech Republic segment operated one general entertainment channel, TV NOVA (Czech Republic), as of December 31, 2016. The Romania segment operated one general entertainment channel, PRO TV, as of December 31, 2016. The Slovak Republic segment operated one general entertainment channel, TV MARKIZA, as of December 31, 2016.
A glance at Central European Media Enterprises Ltd. (NASDAQ:CETV)’s key stats reveals a current market capitalization of 444.70 Million based on 143.55 Million shares outstanding and a price at last close of $3.10 share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-11-01, Tcs picked up 43,000 at a purchase price of $2.46. This brings their total holding to 17,097,951 as of the date of the filing.
On the sell side, the most recent transaction saw Penn unload 17,200 shares at a sale price of $3.04. This brings their total holding to 149,643.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Central European Media Enterprises Ltd. (NASDAQ:CETV) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.